FindTrial
Sign In

The efficacy of sirolimus in different genotypes of low-flow vascular malformations

The efficacy of sirolimus in different genotypes of low-flow vascular malformations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035480
Enrollment
Unknown
Registered
2020-08-12
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low-flow vascular malformation

Interventions

Case series:Oral sirolimus treatment

Sponsors

Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 60 Years

Inclusion criteria

Inclusion criteria: Low-flow vascular malformation patients.

Exclusion criteria

Exclusion criteria: Patients with sever or uncontrolled diseases which are not elegible to the clinical trail.

Design outcomes

Primary

MeasureTime frame
rate of lesion volume drease;—

Secondary

MeasureTime frame
rate of effectiveness;—

Countries

China

Contacts

Public ContactLin Xiaoxi

Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

linxiaoxi@126.com+86 13701997136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026